Influenza A H7N9 virus

Formats

Anti-Influenza A H7N9 virus Recombinant Antibody Products

Human Anti-Influenza A H7N9 virus Recombinant Antibody (HPAB-0169-YJ) (HPAB-0169-YJ)
- Species Reactivity: Influenza A H7N9 virus
- Type: Human IgG1, κ
- Application: ELISA, Neut, Inhib, Block, FuncS
Compare

Human Anti-Influenza A H7N9 virus Recombinant Antibody; scFv Fragment (HPAB-0169-YJ-S(P)) (HPAB-0169-YJ-S(P))
- Species Reactivity: Influenza A H7N9 virus
- Type: Human scFv
- Application: ELISA, Neut, Inhib, Block, FuncS
Compare

Human Anti-Influenza A H7N9 virus Recombinant Antibody; Fab Fragment (HPAB-0169-YJ-F(E)) (HPAB-0169-YJ-F(E))
- Species Reactivity: Influenza A H7N9 virus
- Type: Human Fab
- Application: ELISA, Neut, Inhib, Block, FuncS
Compare

More Infomation

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.

H7N9 is a bird flu strain of the species Influenza virus A (avian influenza virus or bird flu virus). Avian influenza A H7 viruses normally circulate amongst avian populations with some variants known to occasionally infect humans. An H7N9 virus was first reported to have infected humans in March 2013, in China. The CDC estimates that the H7N9 virus has the greatest potential compared with other influenza A viruses to cause a pandemic, although the risk is low, because like other type A viruses, it is not easily transmitted between people in its current form.